Form 4: Elevance Health Director Bahija Jallal Reports Acquisition of Deferred Stock Units

Director Bahija Jallal reports acquisition of deferred stock units in Elevance Health, Inc.

Summary

• On May 14, 2025, Bahija Jallal, a director of Elevance Health, Inc., acquired 601 deferred stock units.
• These units were accrued under the company's Board of Directors Compensation Program.
• The deferred stock units will be payable in Elevance Health, Inc. common stock.
• Payment will occur upon the earlier of (a) five years from the grant date or (b) the date Jallal ceases to be a board member, unless a later date is designated under the Deferred Compensation Plan.
• Following the transaction, Jallal beneficially owns 4,788 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a transaction by a company director. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Future Outlook

The deferred stock units will be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Industry Context

This filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies. It provides transparency into the holdings and transactions of company directors.

Stakeholder Impact

• The acquisition of deferred stock units by a director signals alignment of interests between the director and shareholders.
• This type of transaction is part of the director's compensation and does not have an immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Elevance Health, Director, Form 4, Deferred Stock Units, Beneficial Ownership, Bahija Jallal